Morgan Stanley initiated coverage on COMPASS Pathways with a new price target

4/1/24 7:29:23 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Morgan Stanley initiated coverage of COMPASS Pathways with a rating of Overweight and set a new price target of $30.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CMPS

Date	Price Target	Rating	Analyst
2/27/2025	$11.00	Buy	Stifel
7/23/2024	$23.00	Outperform	RBC Capital Mkts
4/1/2024	$30.00	Overweight	Morgan Stanley
12/12/2023	$16.00	Buy	Deutsche Bank
11/21/2022	$33.00	Buy	Berenberg
11/1/2022	$34.00	Buy	Loop Capital
11/22/2021	$100.00 → $120.00	Buy	HC Wainwright & Co.
10/29/2021	$50.00	Outperform	Oppenheimer